Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. - Test2 - elhamkhani - TriplyDB

Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma.

Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma.

http://www.wikidata.org/entity/Q33831996

about

The MST/Hippo Pathway and Cell Death: A Non-Canonical Affair Alteration of Epigenetic Profile in Human Hepatocellular Carcinoma and Its Clinical Implications The important molecular markers on chromosome 17 and their clinical impact in breast cancer Epigenetic regulations of inflammatory cyclooxygenase-derived prostanoids: molecular basis and pathophysiological consequences Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma Gene expression and hepatitis C virus infection Epigenetic impact of infection on carcinogenesis: mechanisms and applications Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCs Molecular classification and novel targets in hepatocellular carcinoma: recent advancements Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma Methylation of the CpG sites only on the sense strand of the APC gene is specific for hepatocellular carcinoma Network-based regularization for matched case-control analysis of high-dimensional DNA methylation data.A meta-analysis on age-associated changes in blood DNA methylation: results from an original analysis pipeline for Infinium 450k data.Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis.A pilot study of proteomic profiles of human hepatocellular carcinoma in the United States.Glutathione S-Transferase P1 (GSTP1) gene polymorphism increases age-related susceptibility to hepatocellular carcinoma.DNA methylation: potential biomarker in Hepatocellular Carcinoma.Methylation of Dickkopf-3 as a prognostic factor in cirrhosis-related hepatocellular carcinoma Reprimo tissue-specific expression pattern is conserved between zebrafish and human.DNA methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection.Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis.Promoter hypermethylation of Wnt pathway inhibitors in hepatitis C virus - induced multistep hepatocarcinogenesis.Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignancies Expression of DNA methyltransferases is influenced by growth hormone in the long-living Ames dwarf mouse in vivo and in vitro.High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma.Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma.Low frequency of Lynch syndrome among young patients with non-familial colorectal cancer.Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice.Viral hepatocarcinogenesis.Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.Unique association between global DNA hypomethylation and chromosomal alterations in human hepatocellular carcinoma.Dark matters in AMD genetics: epigenetics and stochasticity Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review.Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study TP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinoma.Differential methylation of the promoter and first exon of the RASSF1A gene in hepatocarcinogenesis.Integrative epigenomic and genomic filtering for methylation markers in hepatocellular carcinomas.DNA markers in molecular diagnostics for hepatocellular carcinoma.Chronic liver inflammation modifies DNA methylation at the precancerous stage of murine hepatocarcinogenesis.

P2860

Q26744308-608B3936-4B0D-47F9-866E-8187FD4826FA Q26797616-BEAF07EB-86C1-4B10-9E6D-0B0D457FA2BE Q26859002-7F77B2E5-6CD9-4FB7-BF75-F38351111CF4 Q26862642-7ADF4458-9522-4D25-909D-9C1A0CEDD6FF Q27023524-AC82258F-ACA6-461C-8845-99578F44A097 Q27488345-8980C018-1168-415A-BCDC-699DAABABC6F Q28066519-C3F4AE18-D0B7-4AEC-A8A0-B0B479C03C84 Q28305454-29B0DD7B-4677-4C61-8718-2D6CD0A88B1C Q28383646-0B54E1C8-BCF2-4856-A4F2-276252212705 Q28730441-55FEBD6D-6D69-49D8-8AFF-EC0FAE0AD2AC Q28743228-BF19E314-CFE7-4505-B74D-5D4E4AD5BFC0 Q30580203-12904A97-2855-417B-A61E-C399877D214D Q30896785-851BBE13-2F8D-4674-8ACB-CA111D2909D4 Q31021133-C2EA56BB-5550-4458-A87B-6EDA1219F0E7 Q33470083-359CC23B-949A-499E-B954-FA5A7893DF9E Q33544926-69277D87-6626-46F3-A4F1-1414DD138F6D Q33617129-213D21FE-6110-47DC-9EE5-DD00CC12D7EF Q33632373-B6747EC8-07CE-4216-A093-146338FBE661 Q33745928-C3A33B2C-AB90-462A-A6E9-C39A943333E4 Q33766987-2F331EB6-454A-40C0-BFF2-559C6B4890F5 Q33785451-2D8B8908-435C-46B2-B932-E29D7D851572 Q33826718-9B67E653-1897-41D0-976A-EFD3CF9442A5 Q33907989-86A952E2-C84D-4ADD-B715-1B42B3797355 Q33951579-73747A18-D901-4F3A-8201-385A98AD3D0D Q33966440-11434F31-C254-4F35-8179-5848099B243F Q34168643-54B91A69-ADEB-4CFB-BD78-00AC6D5E07E1 Q34242626-736D4D81-C22B-4615-80EC-9294E4F8D130 Q34268708-12F12CD8-0594-48E1-8376-C96A0FE3FF57 Q34403470-DBFF3103-F4D3-4C3E-90A6-E2A143A6BAA1 Q34617749-A46F727C-C230-4302-8B3E-80F3EE1E5E1A Q34765478-212F2B94-35C2-4F7A-BC99-D27C3BDEC0BE Q34983911-AE15E521-1083-4947-8F03-E64C94455F61 Q35005822-6932C156-C722-4E5D-BD98-2BF1A3A19CD2 Q35084738-5BDB5428-B80A-4A19-BB74-447060B0897A Q35135769-62A1367F-5943-430D-91E6-951A6A6993C6 Q35368917-995FD6EF-CDD8-4358-B3A1-381A54BF84F3 Q35589600-79F1982E-F8F6-49A2-8293-B26E23D1B104 Q35658932-0B043482-E879-47B2-9A08-00202F54118D Q35781255-295744D6-1645-4E8D-8B17-F0589306AE00 Q35793705-1623846D-3618-49E9-B0E0-350C5E595A55

P2860

Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma.

http://www.wikidata.org/entity/Q33831996

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

Aberrant methylation of multip ...... and hepatocellular carcinoma.

@ast

Aberrant methylation of multip ...... and hepatocellular carcinoma.

@en

type

label

Aberrant methylation of multip ...... and hepatocellular carcinoma.

@ast

Aberrant methylation of multip ...... and hepatocellular carcinoma.

@en

prefLabel

Aberrant methylation of multip ...... and hepatocellular carcinoma.

@ast

Aberrant methylation of multip ...... and hepatocellular carcinoma.

@en

P1433

Q33831996-2ECA8982-61E7-4026-A094-6523C85AA6A7

P1476

Q33831996-329FD32A-B0FC-4C31-BA4E-E965DF7DD44C

P2093

Q33831996-526DEBE2-7267-4412-A3C6-B3DF45772D34

Q33831996-8680B3AC-9C6E-4F1B-82E2-852787E43B77

Q33831996-9C7A7778-BE6E-4869-BE92-F7646EC8B4A1

Q33831996-E2CB5084-F149-46EF-9F8B-E79C5BE3F8BA

P2860

Q33831996-0FA1A644-6E98-45D4-A800-DECE5724535B

Q33831996-1031D07D-835F-4A43-A39A-317532A6229C

Q33831996-12DCC916-A20B-474F-AF47-E29FEDED8765

Q33831996-1D01780F-05C4-44F3-8105-D5ADABFA45C3

Q33831996-449EA104-5345-43DD-90E8-04A87AD34F3B

Q33831996-66BD2786-4A30-4C3C-960B-DEF8D1C4DB79

Q33831996-74F08C9A-A65E-4145-841B-199691CDD65B

Q33831996-780EAAD9-2691-4106-A4BE-1AAD5D80FE83

Q33831996-7D7D5EB7-199E-4A3D-939C-AC54F279F1A2

Q33831996-9B9CCB97-8B31-40B9-AC43-6D7D32710DA7

P304

Q33831996-CF4C6B3B-3CE1-47DC-9F41-3E45F3D14719

P31

Q33831996-F3622B78-B53E-40D6-887D-B3E1CD8BEC12

P356

Q33831996-C0B6532B-2F1E-495A-9E14-6A51B5F08B42

P407

Q33831996-32BAFF86-55DF-4334-B373-51A939753C01

P433

Q33831996-DFF97FB9-F4A6-46B1-A369-3E07C69003F1

P478

Q33831996-071708EE-3101-41D5-94D9-C7BA631B8FBB

P50

Q33831996-005E1FF7-CE31-477B-8BCF-4540CAB8103F

Q33831996-A1E5D3D1-D2F5-4C43-A1C5-87C1A940E7BA

P577

Q33831996-1C162CA1-E14E-4CD2-BAAC-C8117E81764B

P5875

Q33831996-BF69EF01-D592-40EA-907E-B0945886CC7E

P698

Q33831996-65809421-C61E-4115-AB36-C66632743E7A

P932

Q33831996-65CC1724-4988-4992-8CC5-B96BD0BA01C5

P356

P1433

P1476

Aberrant methylation of multip ...... , and hepatocellular carcinoma

@en

P2093

C Richard Boland

http://www.w3.org/2001/XMLSchema#string

Iwao Ikai

http://www.w3.org/2001/XMLSchema#string

Naoshi Nishida

http://www.w3.org/2001/XMLSchema#string

Takafumi Nishimura

http://www.w3.org/2001/XMLSchema#string

P2860

Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.

Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma

A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.

MGMT promoter methylation and field defect in sporadic colorectal cancer.

COBRA: a sensitive and quantitative DNA methylation assay.

Focus on hepatocellular carcinoma.

Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.

Methylation inhibitor therapy in the treatment of myelodysplastic syndrome.

Combination therapy with DNA methyltransferase inhibitors in hematologic malignancies.

P304

908-918

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.22110

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

Takeshi Nagasaka

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5688477

http://www.w3.org/2001/XMLSchema#string

P698

18161048

http://www.w3.org/2001/XMLSchema#string

P932

2865182

http://www.w3.org/2001/XMLSchema#string